Trasis is a company committed to advancing nuclear medicine and radiopharmaceutical technology. They focus on providing the medical community with easier and faster access to new radiolabelled therapeutic and diagnostic substances. Trasis designs, manufactures, sells, and supports high-performance synthesizers, dose preparation, and dispensing equipment.
Focus Areas
Notable Investments